DNAJB14 Antibody

What is the biological function of DNAJB14 protein?

DNAJB14 functions primarily as a co-chaperone with HSPA8/Hsc70, playing crucial roles in protein homeostasis within the endoplasmic reticulum (ER). It promotes protein folding and trafficking, prevents aggregation of client proteins, and facilitates the targeting of unfolded proteins to the endoplasmic reticulum-associated degradation (ERAD) pathway . DNAJB14 regulates HSPA8/Hsc70's ATPase and polypeptide-binding activities . Additionally, it can function independently of HSPA8/Hsc70, working together with DNAJB12 to promote maturation of potassium channels like KCND2 and KCNH2 by stabilizing nascent channel subunits and assembling them into tetramers . Recent research has also implicated DNAJB14 in viral infections, particularly in polyomavirus endoplasmic reticulum membrane penetration .

What is the cellular localization and topology of DNAJB14?

DNAJB14 is an ER-localized, type-II transmembrane protein. Immunofluorescence studies using HA-tagged DNAJB14 show co-localization with calnexin, confirming its ER localization . Proteinase K protection assays reveal that DNAJB14 has its J-domain facing the cytosol, while its C-terminus resides in the ER lumen . This topology is critical for its function, as it allows the protein to interact with cytosolic Hsc70 via its J-domain while maintaining contact with ER luminal proteins. The N-terminus, including the J-domain, is susceptible to proteinase K digestion when microsomes are intact, while the C-terminus is protected, suggesting a type-II transmembrane orientation .

How does DNAJB14 interact with Hsc70, and what is the significance of the HPD motif?

DNAJB14 interacts with cytosolic Hsc70 via its J-domain, which protrudes into the cytosol. This interaction is critical for DNAJB14's co-chaperone functions. Immunoprecipitation studies have demonstrated that DNAJB14 co-purifies with Hsc70, confirming their direct interaction . The interaction specifically requires an intact HPD motif within the J-domain of DNAJB14. Mutation of this conserved motif (D138N, changing HPD to HPN) abolishes the interaction with Hsc70 . This finding aligns with the general understanding that the HPD motif is essential for J-protein recognition of Hsp70 family members. The interaction between DNAJB14 and Hsc70 is functionally significant as it enables DNAJB14 to stimulate Hsc70's ATPase activity, which is necessary for client protein processing and ERAD functions .

What are the differences between DNAJB14 and DNAJB12 in terms of function and experimental approaches?

While DNAJB14 and DNAJB12 share structural and functional similarities, they exhibit distinct characteristics that require different experimental approaches:

Both proteins cooperate in certain functions, such as in potassium channel maturation, where they work together to stabilize nascent channel subunits and facilitate tetramer assembly .

How can researchers investigate DNAJB14's role in ERAD using appropriate model substrates?

Investigating DNAJB14's role in ERAD requires careful selection of model substrates and experimental approaches:

• Selection of appropriate model substrates: Research has shown that DNAJB14 specifically enhances the degradation of membrane proteins but not luminal proteins. For example, while DNAJB14 overexpression accelerates the degradation of CFTR-ΔF508 (a membrane protein), it has no effect on A1AT-NHK (a luminal protein) . Researchers should select membrane protein substrates that are known ERAD targets, such as:

  • CFTR-ΔF508 (cystic fibrosis transmembrane conductance regulator with ΔF508 mutation)

  • TCRα (T-cell receptor alpha chain)

  • Potassium channels KCND2 and KCNH2

• Experimental approaches:

  • Pulse-chase experiments with radioisotope labeling to track protein degradation kinetics

  • Co-immunoprecipitation to detect interactions between DNAJB14 and substrate proteins

  • Proteasome inhibition studies to confirm the ERAD pathway involvement

  • Comparison of wild-type DNAJB14 with J-domain mutants (e.g., D138N) to assess J-domain dependency

  • siRNA knockdown or CRISPR knockout of DNAJB14 to evaluate effects on substrate stability

• Controls and validation:

  • Include both membrane and luminal ERAD substrates to confirm specificity

  • Examine effects of DNAJB12 for comparison

  • Use proteasome inhibitors (e.g., MG132) to confirm that observed degradation occurs via ERAD

What are the optimal conditions for using DNAJB14 antibodies in immunofluorescence and immunohistochemistry?

Optimizing DNAJB14 antibody use in immunofluorescence (IF) and immunohistochemistry (IHC) requires attention to several parameters:

For Immunofluorescence (IF/ICC):

• Fixation and permeabilization:

  • Recommended fixation: 4% paraformaldehyde for 15-20 minutes at room temperature

  • Permeabilization: 0.1-0.3% Triton X-100 for 5-10 minutes

  • For membrane proteins like DNAJB14, alternative permeabilization with 0.1-0.2% saponin may better preserve membrane structure

• Blocking and antibody incubation:

  • Block with 5% normal serum (matching secondary antibody species) with 0.1% BSA

  • Primary antibody dilution: 1:200-1:800 (optimize for each specific antibody)

  • Incubation: Overnight at 4°C or 1-2 hours at room temperature

  • Secondary antibody: Highly cross-adsorbed versions recommended (e.g., Alexa Fluor 488 or 647)

• Validation controls:

  • Co-staining with established ER markers (e.g., calnexin)

  • Peptide competition to confirm specificity

  • Use of cells with DNAJB14 knockdown/knockout as negative controls

For Immunohistochemistry (IHC):

• Antigen retrieval:

  • Recommended method: Heat-induced epitope retrieval with TE buffer pH 9.0

  • Alternative: Citrate buffer pH 6.0

  • Critical step for consistent results with formalin-fixed paraffin-embedded tissues

• Antibody dilution and detection:

  • Working dilution: 1:200-1:800 (specific to antibody source)

  • Incubation time: 1 hour at room temperature or overnight at 4°C

  • Detection system: HRP-polymer or avidin-biotin based systems

• Specificity controls:

  • Positive tissue controls (human testis and ovary tissues show reliable expression)

  • Negative controls (primary antibody omission and isotype controls)

What are the key considerations when designing experiments to study DNAJB14-Hsc70 interactions?

Designing experiments to study DNAJB14-Hsc70 interactions requires careful consideration of several factors:

• Co-immunoprecipitation approaches:

  • Use anti-DNAJB14-C antibody for immunoprecipitation (4 μg per 1-3 mg total protein)

  • Buffer composition: 150 mM NaCl, 20 mM Tris-HCl (pH 7.5), 1% Triton X-100, with protease inhibitors

  • Include controls: wild-type DNAJB14 vs. J-domain mutant (D138N)

  • Detect interaction by immunoblotting with anti-Hsc70 antibodies

• ATP dependency studies:

  • Include conditions with/without ATP (1-5 mM)

  • Test ADP vs. ATP to distinguish binding states

  • Consider non-hydrolyzable ATP analogs (ATP-γS) to trap specific interaction states

• Functional assays:

  • ATPase activity assays to measure DNAJB14 stimulation of Hsc70 ATPase activity

  • Protein refolding assays with model substrates

  • Client protein binding studies in presence/absence of DNAJB14 and ATP

• Structural considerations:

  • The J-domain (especially the HPD motif) is critical for Hsc70 interaction

  • Topology is important: ensure experimental designs account for DNAJB14's transmembrane orientation

  • Consider the impact of detergents on membrane protein structure and interactions

• Advanced techniques:

  • Proximity ligation assays for in situ detection of interactions

  • FRET-based approaches for real-time interaction studies

  • In vitro reconstitution with purified components

How can researchers troubleshoot non-specific binding when using DNAJB14 antibodies in Western blotting?

Non-specific binding is a common challenge when working with DNAJB14 antibodies in Western blotting. Here are systematic approaches to troubleshoot this issue:

• Antibody selection and validation:

  • Different epitope recognition: Consider using antibodies targeting different regions (N-terminal vs. C-terminal)

  • Validate specificity with knockout/knockdown controls

  • Confirm the expected molecular weight (~42 kDa for full-length DNAJB14)

• Sample preparation optimization:

  • Extraction buffer: Use RIPA buffer with 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris (pH 8.0)

  • Include protease inhibitors to prevent degradation

  • For membrane proteins, consider mild detergents (digitonin or DDM) for better preservation

• Blocking and antibody incubation:

  • Empirically test different blocking agents:

    • 5% non-fat dry milk in TBST (standard)

    • 5% BSA in TBST (often better for phospho-specific antibodies)

    • Commercial blocking buffers

  • Increase blocking time (1-2 hours at room temperature)

  • Optimize primary antibody dilution (1:500-1:3000)

  • Extend washing steps (5 × 5 minutes with TBST)

• Technical adjustments:

  • Use fresh transfer buffer and ensure complete transfer

  • Consider semi-dry vs. wet transfer based on protein size

  • Increase SDS-PAGE separation distance for better resolution

  • Use gradient gels for improved separation of similar-sized proteins

• Signal detection optimization:

  • Adjust exposure time to prevent overexposure

  • Consider ECL substrates of appropriate sensitivity

  • For weak signals, try signal enhancement systems or more sensitive detection methods

• Specific considerations for DNAJB14:

  • Expression levels: DNAJB14 is expressed at relatively low levels in many cell types

  • Glycosylation status: Check if differential glycosylation causes band shifts

  • Consider enrichment by immunoprecipitation before Western blotting for low-abundance samples

How can DNAJB14 antibodies be used to investigate its role in viral infection pathways?

DNAJB14 has been implicated in viral infection pathways, particularly for polyomaviruses . Researchers can use DNAJB14 antibodies to investigate these roles through several approaches:

• Infection model systems:

  • Establish cell culture models susceptible to polyomavirus infection

  • Compare wild-type cells with DNAJB14 knockdown/knockout cells

  • Monitor virus entry, ER penetration, and replication

• Visualization of DNAJB14-virus interactions:

  • Immunofluorescence co-localization studies (1:200-1:800 dilution) of DNAJB14 with viral proteins during infection

  • Live-cell imaging using fluorescently-tagged DNAJB14 and viral components

  • Electron microscopy with immunogold labeling to visualize DNAJB14 at sites of viral ER penetration

• Biochemical approaches:

  • Co-immunoprecipitation of DNAJB14 with viral proteins using anti-DNAJB14 antibodies (0.5-4.0 μg for IP)

  • Analyze changes in DNAJB14 expression, modification, or localization during viral infection

  • Examine interactions between DNAJB14, Hsc70, and viral proteins during different infection stages

• Functional studies:

  • Rescue experiments in DNAJB14-deficient cells with wild-type vs. mutant DNAJB14

  • Structure-function analysis to identify domains critical for viral infection

  • Quantitative assessment of viral entry and replication efficiency

• Therapeutic implications:

  • Screen for compounds that modulate DNAJB14-virus interactions

  • Evaluate anti-viral strategies targeting DNAJB14-dependent pathways

What approaches can be used to study DNAJB14's role in potassium channel maturation?

DNAJB14, together with DNAJB12, promotes the maturation of potassium channels like KCND2 and KCNH2 by stabilizing nascent channel subunits and facilitating their assembly into tetramers . Researchers can investigate this process using several approaches:

• Expression systems and model development:

  • Heterologous expression of potassium channels in cell lines with manipulated DNAJB14 levels

  • Use of temperature-sensitive folding mutants of channel proteins to study chaperone effects

  • Development of fluorescently tagged channel subunits to track assembly in real-time

• Biochemical characterization:

  • Pulse-chase experiments to track channel protein stability

  • Glycosylation analysis to monitor ER-to-Golgi trafficking

  • Blue native PAGE to visualize channel tetramer assembly

  • Co-immunoprecipitation with anti-DNAJB14 antibodies to detect channel-chaperone complexes

• Functional assessment:

  • Patch-clamp electrophysiology to measure channel function

  • Surface biotinylation to quantify membrane-localized channels

  • Current density measurements in cells with normal vs. altered DNAJB14 expression

• Mechanistic studies:

  • Distinguish Hsc70-dependent vs. Hsc70-independent functions using DNAJB14 J-domain mutants

  • Comparative analysis of DNAJB14 and DNAJB12 contributions to channel maturation

  • Structure-function analysis to identify critical domains in DNAJB14 for channel interaction

• Disease-relevant contexts:

  • Studies in cardiac cells for KCNH2 (hERG channel) related to Long QT syndrome

  • Neuronal models for KCND2 (Kv4.2 channel) related to neurological disorders

  • Investigation of channel mutations that might affect chaperone interactions

How should researchers approach comparative studies of DNAJB14 expression across different tissues and under various stress conditions?

Studying DNAJB14 expression patterns across tissues and stress conditions requires systematic approaches:

• Baseline expression profiling:

  • Western blot analysis of tissue lysates using anti-DNAJB14 antibodies (1:500-1:3000 dilution)

  • Immunohistochemistry of tissue arrays (1:200-1:800 dilution)

  • RT-PCR analysis of DNAJB14 mRNA levels (33 cycles recommended for detection)

  • Consider digital PCR for more accurate quantification of low-abundance transcripts

• Stress condition experimental design:

  • ER stress induction: tunicamycin (0.5-2 μg/mL), thapsigargin (100-300 nM), DTT (1-2 mM)

  • Heat shock: 42°C for 1-2 hours followed by recovery periods

  • Compare with known stress-responsive genes (e.g., BiP, XBP1, HSP47)

  • Time-course analysis to capture early and late responses

• Single-cell analysis approaches:

  • Immunofluorescence to detect cell-to-cell variation in DNAJB14 expression

  • Flow cytometry with intracellular staining

  • Single-cell RNA-seq for comprehensive expression profiling

• Validation strategies:

  • Multiple antibodies targeting different epitopes

  • Correlation between protein and mRNA levels

  • Comparison with publicly available expression databases

  • Inclusion of appropriate housekeeping genes/proteins as controls

• Data analysis considerations:

  • Normalization strategies for cross-tissue comparison

  • Statistical approaches for detecting significant changes

  • Correlation analysis with other chaperones (e.g., DNAJB12, Hsc70)

  • Bioinformatic analysis of regulatory elements in the DNAJB14 promoter

Previous research has shown that unlike some ER chaperones, DNAJB14 is not significantly upregulated during ER stress or heat shock . This distinguishes it from many stress-inducible chaperones and suggests constitutive functions, requiring sensitive detection methods for accurate expression analysis.

What are the implications of DNAJB14-associated DJANGOs for nuclear protein quality control?

When overexpressed, DNAJB14 forms membranous structures together with DNAJB12 and HSPA8/Hsc70 within the nucleus, termed DJANGOs . Though their precise role remains unclear, researchers can investigate these structures using the following approaches:

• Characterization approaches:

  • High-resolution microscopy (confocal, super-resolution) using anti-DNAJB14 antibodies (1:200-1:800 for IF)

  • Co-localization studies with nuclear membrane markers and chromatin

  • Electron microscopy to characterize ultrastructure

  • Biochemical isolation of DJANGO components followed by proteomics

• Functional investigations:

  • Correlation with nuclear protein quality control events

  • Analysis of client proteins associated with DJANGOs

  • Effects on chromatin organization and gene expression

  • Relationship to nuclear stress bodies and other nuclear compartments

• Regulation studies:

  • Conditions promoting DJANGO formation beyond overexpression

  • Cell cycle dependence of DJANGO assembly/disassembly

  • Relationship to cellular stress responses

• Disease relevance:

  • Examination of DJANGO formation in protein misfolding diseases

  • Potential roles in viral replication compartments

  • Association with nuclear envelope pathologies

How can differential epitope accessibility be exploited for studying DNAJB14 conformational changes and interactions?

The availability of antibodies recognizing different epitopes of DNAJB14 (N-terminal vs. C-terminal regions) provides opportunities to study conformational dynamics and protein interactions:

• Conformational change detection:

  • Comparative immunoprecipitation with N- and C-terminal antibodies under different conditions

  • Epitope masking assays to detect interaction-induced conformational changes

  • FRET-based reporters incorporating different epitope regions

• Topology and membrane integration studies:

  • Combined use of N- and C-terminal antibodies in protease protection assays

  • Accessibility analysis in intact cells vs. permeabilized cells

  • Domain-specific labeling approaches

• Interaction mapping:

  • Determine which epitopes become inaccessible upon specific protein interactions

  • Antibody competition assays to map binding interfaces

  • Epitope-specific co-immunoprecipitation to identify domain-specific interactions

• Methodological considerations:

  • Selection of appropriate antibody pairs with validated epitope specificity

  • Optimization of fixation and permeabilization conditions for epitope preservation

  • Controls to distinguish conformational changes from epitope masking by other proteins